In line with what has been shown for other tumor suppressors, we observe that MIR34B/C undergo an epigenetic switch from polycomb mediated gene silencing to permanent gene silencing by DNA methylation during lymphomagenesis [39–41]. Here, MIR34B is linked to neoplasm.